ABOUT
General Life Biotechnology
Established in 1999 in Taiwan, General Life Biotechnology, operating under the distinguished brand BeneCheck, is a company dedicated to the manufacturing and research of medical testing products. In 2015, we became a part of the Compal Group, expanding not only our global market influence but also providing more opportunities for collaboration and development. Our primary products include blood glucose monitors and multi-function analyzers, covering tests for glucose, uric acid, and total cholesterol. In recent years, we have continued to innovate, introducing tests for blood ketones and hemoglobin to comprehensively meet the diverse needs of our customers. The core technologies of our company are rooted in electrochemical and screen printing techniques, enabling us to provide advanced and reliable medical testing solutions. Not only do we excel in technology, but we also uphold the highest standards in our manufacturing and research processes, certified by the ISO 13485 quality system. Furthermore, our products have obtained certifications including CE, TFDA, NMPA, reinforcing our position in the industry.
Commitment to quality and innovation
Under the brand name BeneCheck, GLB has gained recognition for its commitment to quality and innovation. The company's products are widely used by healthcare professionals and individuals worldwide. In addition to its own brand, GLB also provides contract manufacturing services, offering OEM production for various trusted brands in the healthcare industry.
With a strong emphasis on research and development, GLB continually strives to enhance its product offerings and meet the evolving needs of the healthcare sector. By combining technological expertise, industry partnerships, and a customer-centric approach, GLB remains at the forefront of medical device manufacturing.
